Prediction of relapse and survival in breast cancer patients by pS2 protein status.
暂无分享,去创建一个
J. Foekens | J. Klijn | P. Chambon | W. van Putten | M. Nap | M. Rio | P. Seguin | J. Fauque | Marius Joã«lfauque | Jan G M Nap | Pierre Klijn | Chambã³n
[1] J. Foekens,et al. Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer. , 1989, Cancer research.
[2] J. Foekens,et al. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols. , 1989, Cancer research.
[3] I. Christensen,et al. Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. , 1989, Cancer research.
[4] G. Bonadonna,et al. Cell kinetics as a prognostic indicator in node-negative breast cancer. , 1989, European journal of cancer & clinical oncology.
[5] S. Hirohashi,et al. Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1. , 1989, Cancer research.
[6] G M Clark,et al. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. , 1989, The New England journal of medicine.
[7] G. Bonadonna,et al. Tumor grade as a prognostic factor in primary breast cancer. , 1989, European journal of cancer & clinical oncology.
[8] J. Farndon,et al. EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTORS ASSOCIATED WITH LACK OF RESPONSE TO ENDOCRINE THERAPY IN RECURRENT BREAST CANCER , 1989, The Lancet.
[9] Osborne Ck,et al. Adjuvant treatment of node-negative breast cancer. , 1989 .
[10] D. Merkel,et al. Adjuvant treatment of node-negative breast cancer. , 1989, Texas medicine.
[11] DNA flow cytometry in the prognosis of node-negative breast cancer. , 1989, The New England journal of medicine.
[12] M. J. van de Vijver,et al. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. , 1988, The New England journal of medicine.
[13] R. Lathe,et al. Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. , 1988, Science.
[14] C. Redmond,et al. Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] J. Klijn,et al. The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer , 1988, Cancer.
[16] P Chambon,et al. Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[17] P. Chambon,et al. Characterization of the estrogen-induced pS2 protein secreted by the human breast cancer cell line MCF-7. , 1987, Endocrinology.
[18] J. Farndon,et al. EPIDERMAL-GROWTH-FACTOR RECEPTOR STATUS AS PREDICTOR OF EARLY RECURRENCE OF AND DEATH FROM BREAST CANCER , 1987, The Lancet.
[19] L. Skoog,et al. Prognostic significance of the receptor for epidermal growth factor in human mammary carcinomas. , 1987, Anticancer research.
[20] W. McGuire,et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.
[21] K. Horwitz,et al. Progestin action and progesterone receptor structure in human breast cancer: a review. , 1985, Recent progress in hormone research.
[22] P Chambon,et al. Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7. , 1984, Nucleic acids research.
[23] W. McGuire,et al. Progesterone receptors as a prognostic factor in Stage II breast cancer. , 1983, The New England journal of medicine.
[24] P. Chambon,et al. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. , 1982, Nucleic acids research.
[25] Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. Workshop, held on 16-17 March, 1979, in the Netherlands Cancer Institute. , 1980, European Journal of Cancer.
[26] W. McGuire,et al. Predicting response to endocrine therapy in human breast cancer: a hypothesis. , 1975, Science.
[27] C. Milstein,et al. Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.
[28] J. M. Bremner,et al. Statistical Inference under Restrictions , 1973 .